The Office for Human Research Studies (OHRS) is the Dana-Farber Cancer Institute office that oversees SRC and IRB processes for the Dana-Farber/Harvard Cancer Center.
Scientific Review is a requirement of the NCI Cancer Center Support Grant (CCSG) that funds the DF/HCC. All cancer-relevant research at DF/HCC member institutions must be reviewed and approved by a SRC or through expedited administrative scientific review for prioritization, as permitted by the CCSG. The SRC assesses a research protocols scientific merit, prioritization and feasibility of trial completion, as well as the progress of approved research terminating research that no longer meets those criteria. OHRS manages five SRC panels.
The IRB is an administrative body established to protect the rights and welfare of human research subjects recruited to participate in research activities conducted under the auspices of the institution with which it is affiliated. The DFCI IRB functions as a single IRB of record for the clinical institutions that comprise the DF/HCC. OHRS manages seven IRB panels.
The Senior Human Research Coordinator (Senior HRC) is expected to work independently applying human subject protection regulations, policies and guidance. This individual must have solid oral and writing skills and be able to effectively communicate with research staff at all of the Harvard clinical institutions that operate under the umbrella of the Dana-Farber/Harvard Cancer Center. The Senior HRC reports to the OHRS Associate Director.
Each Senior HRC supervises a small group of protocol management focused Human Research Coordinators.
MINIMUM JOB QUALIFICATIONS:
KNOWLEDGE, SKILLS, AND ABILITIES REQUIRED: